Back to Search
Start Over
Updated results of a phase II study of oral multi-kinase inhibitor sorafenib in sarcomas, CTEP study #7060
- Source :
- Journal of Clinical Oncology. 26:10531-10531
- Publication Year :
- 2008
- Publisher :
- American Society of Clinical Oncology (ASCO), 2008.
-
Abstract
- 10531 Background: The efficacy of sorafenib in sarcomas was suggested in a phase I study in solid tumors. We conducted a multicenter, phase II study of sorafenib in sarcoma patients (pts) with six ...
- Subjects :
- Sorafenib
Oncology
Cancer Research
medicine.medical_specialty
Kinase
business.industry
Phases of clinical research
urologic and male genital diseases
medicine.disease
female genital diseases and pregnancy complications
digestive system diseases
Phase i study
Internal medicine
medicine
heterocyclic compounds
Sarcoma
business
neoplasms
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 26
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........9ce7b67487d347cd0e8d124dd880776a
- Full Text :
- https://doi.org/10.1200/jco.2008.26.15_suppl.10531